Tyra Biosciences, Inc. TYRA
Set alert
21.49 USD +0.16 +0.74%
As of Nov 3, 1:40 PM ET
21.28 Day range 21.94
13.35 52-week range 40.65
- YTD
- -18.27%
- 1 year
- +39.26%
- Open
- 21.50
- Prev close
- 21.33
- Mkt cap
- 1.48B
- Vol
- 119.31K
- Avg vol
- 870.92K
- EPS
- -2.39
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 21.28
- High
- 21.94
- Forward P/E
- -7.70
- Beta
- 0.67
- Short ratio
- 10.93
- Inst. own
- 108.30%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 22.67
- 200-d avg
- 29.87
- 1y target
- 47.45
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 47.45 +120.8% upside
Now 21.49
- Target (low)
- 29.00
- Target (mean)
- 47.45
- Target (high)
- 59.00
Ratings (0m) 15 14 buy · 1 hold · 0 sell
- Strong buy2
- Buy12
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 15
- 1 month ago 15
- 2 months ago 15
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.665 | -0.76 – -0.47 | -0.50 | -33.0% | 0 | 0.0% | 14 |
| Next quarter | -0.67057 | -0.78 – -0.50 | -0.57 | -17.6% | 0 | 0.0% | 14 |
| Current year | -2.64 | -2.85 – -2.20 | -2.01 | -31.2% | 0 | 0.0% | 14 |
| Next year | -2.77 | -3.36 – -2.23 | -2.64 | -5.1% | 0 | 0.0% | 14 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 22, 2026 | Oppenheimer | Reiterated | Outperform | Outperform |
| Sep 22, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 10, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Sep 10, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 4, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 17, 2026 | Jones Trading | Initiated | — | Buy |
| Jun 10, 2026 | B of A Securities | Maintained | Buy | Buy |
| May 19, 2026 | Wolfe Research | Initiated | — | Peer Perform |
| May 14, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 15, 2026 | Guggenheim | Initiated | — | Buy |
| Apr 6, 2026 | Canaccord Genuity | Initiated | — | Buy |
| Mar 20, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 24, 2026 | Cantor Fitzgerald | Initiated | — | Overweight |
| Feb 17, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 13, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Feb 3, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Feb 3, 2026 | Jefferies | Maintained | Buy | Buy |
| Jan 28, 2026 | Barclays | Initiated | — | Overweight |
| Jan 23, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Dec 16, 2025 | Wedbush | Maintained | Outperform | Outperform |
| Sep 3, 2025 | Raymond James | Initiated | — | Strong Buy |
| Aug 22, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 1, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 31, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 18, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 13, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 7, 2025 | UBS | Initiated | — | Buy |
| Nov 11, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 29, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 28, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |